Regulatory & Compliance

Does the Utah H5N1 Mink Outbreak Pose a New Pandemic Risk?
Research & Development Does the Utah H5N1 Mink Outbreak Pose a New Pandemic Risk?

Virologists are particularly concerned about the role of mink as a biological mixing vessel where different influenza strains can swap genes and adapt to mammals. This concern has taken center stage in 2026 as Utah’s captive mink population faces a significant outbreak of the H5N1 bird flu, marking

New PCR Platform Improves Biosecurity Testing for Aquafeeds
Management & Regulatory New PCR Platform Improves Biosecurity Testing for Aquafeeds

White Spot Syndrome Virus serves as a critical proof-of-concept model for testing how long-fragment PCR can improve the accuracy of feed safety evaluations. The rapid expansion of the global shrimp aquaculture industry has reached a pivotal juncture in 2026, where the volume of production must be

Alcon Acquires Neurotech Pharmaceuticals for $550 Million
Management & Regulatory Alcon Acquires Neurotech Pharmaceuticals for $550 Million

Rare retinal diseases like MacTel often lead to the development of abnormal blood vessels and the permanent loss of clear central vision. This challenging medical reality has prompted Alcon, a global leader in eye care, to enter into a definitive agreement to acquire Neurotech Pharmaceuticals for

How Will the FDA’s New Framework Transform Rare Disease Drugs?
Management & Regulatory How Will the FDA’s New Framework Transform Rare Disease Drugs?

The healthcare industry is witnessing a pivotal shift as the Food and Drug Administration fundamentally reimagines the regulatory pathway for treatments targeting rare conditions that affect millions of Americans. While the pharmaceutical landscape has historically prioritized blockbuster drugs

Can Bio-Based Ingredients Replace Synthetic Analgesics?
Management & Regulatory Can Bio-Based Ingredients Replace Synthetic Analgesics?

The structural integrity of topical creams has traditionally relied on synthetic polymers, but starch and beeswax offer a viable path toward creating high-performance bio-based alternatives. This shift represents more than a mere trend in "green" branding; it is a fundamental response to a global

Quest Diagnostics Confirms Major Cyber Breach Affecting Patients
Management & Regulatory Quest Diagnostics Confirms Major Cyber Breach Affecting Patients

The recurrence of high-profile vulnerabilities suggests that large-scale diagnostic providers are still struggling to implement robust protections for sensitive digital health data. In October, Quest Diagnostics, a titan of the American medical testing industry, officially confirmed a significant

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later